Table 1

Patient characteristics
Patient Progression time: time to metastasis (months) Age at primary Tumor size (cm) Histology Fuhrman grade Gender Metastasis location
1 6 51 5 Clear Cell 3 M Lung
2 72 64 3.2 Clear Cell 3 M Lung
3 6 50 10 Clear Cell 3 M Abdominal Wall
4 12 45 7 Clear Cell 3 M Skin
5 12 70 4 Clear Cell 2 M Lung
6 6 58 3 Clear Cell 2 F Colon
7 24 17 13 Clear Cell 3 F Lung
8 36 66 4 Clear Cell 2 M Lung
9 24 64 10.7 Clear Cell 3 M Liver
10 48 69 6 Clear Cell 3 F Skin
11 36 61 8 Clear Cell 3 F Lung
12 24 61 8 Clear Cell 3 F Liver
13 36 68 4.5 Clear Cell 1 M Bone
14 6 56 11 Clear Cell 3 F Pituitary
15 120 47 8 Clear Cell 3 M Testes
16 24 54 6.5 Clear Cell 2 F Soft Tissue
17 48 62 10.5 Clear Cell 3 M Bone
18 156 56 3.5 Clear Cell 3 M Lung
19 108 59 8.5 Clear Cell 2 M Lung
20 12 28 4 Mixed 3 M Lymph Node
21 6 54 Unknown Clear Cell 2 M Lung
22 12 40 3.7 Mixed 4 M Lung
23 6 64 3.5 Clear Cell 2 M Bone
24 84 46 14.5 Clear Cell 2 F Lung
25 36 55 8.5 Clear Cell 2 M Lung
26 36 66 6.5 Clear Cell 2 M Adrenal
27 132 72 5 Clear Cell 2 F Adrenal
28 12 72 6 Mixed 3 F Soft Tissue
29 6 52 3.5 Clear Cell 3 F Bone
30 12 50 12 Clear Cell 2 F Skin
31 6 33 3.5 Clear Cell 2 M Bone
32 36 69 10.5 Clear Cell 3 F Bone
33 12 62 6 Clear Cell 3 M Bone
34 36 47 8 Clear Cell 3 F Lung

Aziz et al.

Aziz et al. BMC Clinical Pathology 2013 13:3   doi:10.1186/1472-6890-13-3

Open Data